Cargando…

Are Some Anticoagulants More Equal Than Others? - Evaluating the Role of Novel Oral Anticoagulants in AF Ablation

Left atrial ablation strategies are being increasingly performed as a Class 1 therapeutic indication for drug refractory paroxysmal atrial fibrillation (AF). Traditionally AF ablation has been performed with patients on uninterrupted warfarin therapy, however over the last few years, novel oral anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sankaranarayanan, Rajiv, Fox, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304256/ https://www.ncbi.nlm.nih.gov/pubmed/27146837 http://dx.doi.org/10.2174/1573403X12666160505113755

Ejemplares similares

Are some mutations more equal than others?
por: Cote-L’Heureux, Auden, et al.
Publicado: (2023)

"ALL ANTIDEPRESSANTS ARE CREATED EQUAL" (SOME ARE MORE EQUAL THAN OTHERS)
por: Doongaji, Dinshaw R
Publicado: (2000)

All insects are equal, but some insects are more equal than others
por: Fischer, Arnout R.H., et al.
Publicado: (2018)

Some hematopoietic stem cells are more equal than others
por: Hock, Hanno
Publicado: (2010)

All nonadherence is equal but is some more equal than others? Tuberculosis in the digital era
por: Stagg, Helen R., et al.
Publicado: (2020)

All B-lines are equal, but some B-lines are more equal than others
por: Boccatonda, Andrea, et al.
Publicado: (2022)

Screening for atrial fibrillation: all invitees are equal, but some are more equal than others?
por: Engdahl, Johan, et al.
Publicado: (2023)

Combatting Covid-19. Or, “All Persons Are Equal but Some Persons Are More Equal than Others?”
por: Harris, John
Publicado: (2020)

A change of perspective in quarkonium production: All data are equal, but some are more equal than others
por: Lourenço, Carlos, et al.
Publicado: (2014)

All Plant Breeding Technologies Are Equal, but Some Are More Equal Than Others: The Case of GM and Mutagenesis
por: Batalha, Luisa, et al.
Publicado: (2021)

Not All Genes Are Equal; Shortage of Histones Affects Some Genes More Than Others
por: Mejia, Robin
Publicado: (2011)

Some are more equal than others: The role of “keystone” species in the degradation of recalcitrant substrates
por: Ze, Xiaolei, et al.
Publicado: (2013)

Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD‐AF and ORBIT‐AF registries
por: Lim, Toon Wei, et al.
Publicado: (2023)

Evaluating equality in prescribing Novel Oral Anticoagulants (NOACs) in England: The protocol of a Bayesian small area analysis
por: Rezaei-Darzi, Ehsan, et al.
Publicado: (2021)

AF in Cancer Patients: A Different Need for Anticoagulation?
por: Sanz, Ana Pardo, et al.
Publicado: (2019)

All metrics are equal, but some metrics are more equal than others: A systematic search and review on the use of the term ‘metric’
por: Adroher, Núria Duran, et al.
Publicado: (2018)

All are equal, but some are more equal than others: social determinants of leisure time physical activity through the lens of intersectionality
por: Mielke, Gregore I., et al.
Publicado: (2022)

Direct Oral Anticoagulants Concentration Testing in Clinical Practice for High-Risk Patients with AF
por: Pukite, K, et al.
Publicado: (2020)

Comparison of uninterrupted direct oral anticoagulation with vitamin‐K antagonists during AF‐ablation in the clinical routine. A single center register
por: Christoph, Marian, et al.
Publicado: (2021)

Culture, politics and being more equal than others in COVID-19: some psychological anthropology perspectives
por: Pillay, Indira
Publicado: (2021)

Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke?
por: Cao, Lin, et al.
Publicado: (2015)

Novel reversal agents and laboratory evaluation for direct-acting oral anticoagulants (DOAC): An update
por: Shah, Shagun B, et al.
Publicado: (2019)

Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial
por: Hohnloser, Stefan H, et al.
Publicado: (2020)

Adherence to oral anticoagulant therapy in secondary stroke prevention – impact of the novel oral anticoagulants
por: Luger, Sebastian, et al.
Publicado: (2015)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Choosing the source of healthy controls for studies on myeloid malignancies: all bone marrow cells are created equal, but some are more equal than others
por: Rivière, Jennifer, et al.
Publicado: (2023)

Evaluating the Initiation of Novel Oral Anticoagulants in Medicare Beneficiaries
por: Baik, Seo Hyon, et al.
Publicado: (2016)

Cross-Species Analysis of Glycosaminoglycan Binding Proteins Reveals Some Animal Models Are “More Equal” than Others
por: Boittier, Eric D., et al.
Publicado: (2019)

Practical introduction of novel oral anticoagulants through an anticoagulation nurse. The Leeuwarden model
por: Folkeringa, R. J., et al.
Publicado: (2014)

Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis
por: Vallakati, Ajay, et al.
Publicado: (2016)

All Expanded Criteria Donor Kidneys are Equal But are Some More Equal Than Others? A Population-Cohort Analysis of UK Transplant Registry Data
por: Patel, Kamlesh, et al.
Publicado: (2023)

Investigating the feasibility of recruitment to an observational, quality-of-life study of patients diagnosed with atrial fibrillation (AF) who have experienced a bleed while anticoagulated: EQUAL-AF feasibility study protocol
por: Hutchings, Hayley A., et al.
Publicado: (2022)

Current use of direct oral anticoagulants for atrial fibrillation in Japan: Findings from the SAKURA AF Registry
por: Okumura, Yasuo, et al.
Publicado: (2017)

World Café approach: exploring the future vision of oral anticoagulants for patients with atrial fibrillation (AF) in Ireland
por: Murphy, Aileen, et al.
Publicado: (2020)

Oral Anticoagulation Therapy in Atrial Fibrillation Patients with Advanced Chronic Kidney Disease: CODE-AF Registry
por: Park, Hanjin, et al.
Publicado: (2023)

Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registry
por: Schnabel, Renate B, et al.
Publicado: (2023)

Comparison of Early Complications of Oral Anticoagulants after Totally Thoracoscopic Ablation: Warfarin versus Non-vitamin K Antagonist Oral Anticoagulants
por: Heo, MuHyung, et al.
Publicado: (2023)

Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry
por: Cools, Frank, et al.
Publicado: (2021)

SUPPORT-AF IV: Supporting use of AC through provider prompting about oral anticoagulation therapy for AF clinical trial study protocol
por: Patel, Jay, et al.
Publicado: (2021)

The Role of Anticoagulation Clinics in the Era of New Oral Anticoagulants
por: Testa, Sophie, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n3cf3p1nqvlri5elpegb6m4952